BRD4 and hepatocellular carcinoma: The hypothesis can be verified from the analysis of the clinical and pathological characteristics of 377 patients according to the mRNA expression and the survival curve, which shows that patients with HCC having relatively lower ISX or BRD4 expression had a significantly longer survival time than patients with HCC having relatively higher expression after liver resection.